The stock of Generation Bio Co (NASDAQ:GBIO) last traded at $0.39, up 13.03% from the previous session.
GBIO stock price is now -23.55% away from the 50-day moving average and -76.07% away from the 200-day moving average. The market capitalization of the company currently stands at $26.28M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On November 08, 2022, Canaccord Genuity recently initiated its ‘Buy’ rating on the stock quoting a target price of $9, while ‘William Blair’ rates the stock as ‘Mkt Perform’
In other news, Quinn Anthony G., Director bought 125,791 shares of the company’s stock on Jan 10 ’25. The stock was bought for $120,759 at an average price of $0.96. Upon completion of the transaction, the Director now directly owns 214,286 shares in the company, valued at $83571.54. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 13 ’25, Director Quinn Anthony G. bought 85,000 shares of the business’s stock. A total of $82,450 was incurred on buying the stock at an average price of $0.97. This leaves the insider owning 299,286 shares of the company worth $0.12 million. A total of 31.65% of the company’s stock is owned by insiders.
During the past 12 months, Generation Bio Co has had a low of $0.32 and a high of $4.34. As of last week, the company has a debt-to-equity ratio of 1.09, a current ratio of 5.50, and a quick ratio of 5.50. The fifty day moving average price for GBIO is $0.51296 and a two-hundred day moving average price translates $1.638765 for the stock.
The latest earnings results from Generation Bio Co (NASDAQ: GBIO) was released for 2024-12-31. The net profit margin was -661.91% and return on equity was -91.02% for GBIO. The company reported revenue of $4.19 million for the quarter, compared to $2.88 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 45.52 percent.
